THE EFFECTS OF SEQUENTIAL MITOMYCIN AND BACILLUS CALMETTE-GUERIN TREATMENT VERSUS BACILLUS CALMETTE-GUERIN MONOTHERAPY IN PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER: MITO-BCG (EUDRACT-2017-004540-37)

被引：0
|
作者：
De Nunzio, Cosimo
Leonardo, Costantino
Carbone, Antonio
Pastore, Antonio Luigi
Lombardo, Riccardo
Nacchia, Antonio
Cicione, Antonio
Turchi, Beatrice
Tema, Giorgia
Tubaro, Andrea
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP63-12
引用
收藏
页码：E876 / E876
页数：1
相关论文
共 50 条
  • [1] SAFETY EVALUATION OF SEQUENTIAL MITOMYCIN AND BACILLUS CALMETTE-GUERIN TREATMENT VERSUS BACILLUS CALMETTE-GUERIN MONOTHERAPY IN PATIENTS WITH HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER: MITOBCG STUDY(EUDRACT NUMBER 2017-004540-37)PRELIMINARY RESULTS
    De Nunzio, Cosimo
    Nacchia, Antonio
    Lombardo, Riccardo
    Voglino, Olivia
    Leonardo, Costantino
    Simone, Giuseppe
    Pastore, Antonio
    Tubaro, Andrea
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1080 - E1080
  • [2] Safety evaluation of sequential Mitomycin and Bacillus Calmette-Guerin treatment versus Bacillus Calmette-Guerin monotherapy in patients with high risk non-muscle invasive bladder cancer: MITOBCG study (EUDRACT Number 2017-004540-37) preliminary results
    De, Nunzio C.
    Nacchia, A.
    Lombardo, R.
    Voglino, O. A.
    Baldassarri, V.
    Costantino, L.
    Simone, G.
    Pastore, A.
    Tubaro, A.
    [J]. EUROPEAN UROLOGY, 2021, 79 : S618 - S619
  • [3] Bacillus Calmette-Guerin treatment of non-muscle invasive bladder cancer
    Sylvester, Richard J.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (02) : 113 - 120
  • [4] Bacillus Calmette-Guerin (BCG) and alternatives Drug treatment of high-risk non-muscle invasive bladder cancer
    Leucht, K.
    Foller, S.
    Grimm, Marc-Oliver
    [J]. UROLOGE, 2021, 60 (11): : 1400 - 1408
  • [5] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
    Wang, Ziting
    So, Wei Zheng
    Loh, Kep Yong
    Lim, Yew Koon
    Mahendran, Ratha
    Wu, Qing Hui
    Chiong, Edmund
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
  • [6] Contemporary Cost-Effectiveness Analysis Comparing Sequential Bacillus Calmette-Guerin and Electromotive Mitomycin Versus Bacillus Calmette-Guerin Alone for Patients With High-Risk Non-Muscle-Invasive Bladder Cancer
    Bachir, Bassel G.
    Dragomir, Alice
    Aprikian, Armen G.
    Tanguay, Simon
    Fairey, Adrian
    Kulkarni, Girish S.
    Breau, Rodney H.
    Black, Peter C.
    Kassouf, Wassim
    [J]. CANCER, 2014, 120 (16) : 2424 - 2431
  • [7] Intravesical Thalidomide boosts bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer treatment
    Passos, Gabriela R.
    Camargo, Juliana A.
    Ferrari, Karen L.
    Saad, Mario J. A.
    de Mattos, Amilcar C.
    Reis, Leonardo O.
    [J]. MEDICAL ONCOLOGY, 2018, 35 (01)
  • [8] The Management of Bacillus Calmette-Guerin (BCG) Failure in High-Risk Non-muscle Invasive Bladder Cancer: A Review Article
    Kodera, Ahmed
    Mohammed, Mahmoud
    Lim, Paul
    Abdalla, Omer
    Elhadi, Mohammed
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [9] THE BURDEN OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER AMONG PATIENTS TREATED WITH BACILLUS CALMETTE-GUERIN
    Kopenhafer, L.
    Chang, J.
    Thompson, A.
    Sikirica, S.
    Masters, E. T.
    Cappelleri, J. C.
    Peck, E. Y.
    Maculaitis, M. C.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S557 - S557
  • [10] Comparative study between mitomycin C versus Bacillus Calmette-Guerin (BCG) in high-risk non-muscle-invasive bladder cancer
    Zaza, Mohamed Mahmoud Abdelfatah
    Salem, Tarek Abd El-Mageed
    El-Sadat, Ahmed Mohamed
    Ali, Mohammed Hassan
    [J]. UROLOGIA JOURNAL, 2024, 91 (01) : 61 - 68
12345